ABOUT KAYENTIS
Kayentis, a global leader in eCOA and Decentralized Clinical Trial solutions, empowers pharma, biotech, and CROs to streamline data collection in clinical trials, enhancing simplicity, efficiency, and data quality. Since 2005, Kayentis has spearheaded clinical development, specializing in eCOA solutions across phases I-IV in diverse therapeutic areas. Adapting to the changing landscape, Kayentis now offers a comprehensive suite of services to support the shift towards decentralized and hybrid trials, with operational capabilities across the USA, Europe, and Asia.
NEWS
FEATURED ARTICLES
-
Explore the rising prevalence of NASH/MASH, its debilitating effects, and the urgent need for patient-centric approaches in clinical research.
-
Understand why efficient ePRO solutions are essential in measuring patients' perception of their symptoms and quality of life in ophthalmology research.
-
Discover the essential elements for running asthma clinical trials. With several unique specifications to consider, it's crucial to understand the key factors that lead to success.
-
Gain valuable insights into the distinctive needs and challenges that small biotech firms face when conducting clinical trials.
-
When caregivers are involved in a clinical trial, remember to utilize these tactics to ensure that the completion of Observer Reported Outcomes is user-friendly and upholds data quality standards.
-
In this second episode on pediatric clinical trial challenges, industry experts provide insight into their experiences and recommendations on the use of decentralized clinical trial features for pediatric research.
-
Discover how embedding a televisit feature directly into an eCOA app brings multiple benefits to patients and sites.
-
What considerations are required for implementing a DCT? Estelle Haenel, Medical Director at Kayentis, shares valuable insights on how to select a DCT strategy and ensure that DCTs remain patient-focused.
VIDEOS
CONTACT INFORMATION
Kayentis
186 South Street Suite 600
Boston, MA 02111
UNITED STATES
Contact: Guillaume Juge, CEO
BROCHURES
-
Amidst the pressures of time, costs, and limited resources, biotechs urgently need trusted partners for clinical trial success; Kayentis stands ready to fulfill that role.
-
Choose a strong partner to ensure the success of your decentralized clinical trials.
-
Delve into the benefits of implementing a "Bring Your Own Device" strategy into eCOA trials.
-
Learn how Kayentis manages the growing complexities of eCOA trials with its highly flexible eCOA solution, customized eDiaries, and interoperable platform.
-
Learn what sets Kayentis' unified platform for eCOA and DCTs apart from others in the life sciences industry.
-
Results of a survey of investigator sites conducted in November 2022, and co-developed with a group of worldwide site experts: 239 site respondents across the world, in various roles, and carrying out research across multiple therapeutic areas.
-
Ameliorate your eCOA data collection and clinical trial efficiency with Kayentis and ClinOne's combined solution, covering eCOA, virtual visits, consent management, patient engagement, and more.
-
Discover why 95.6% of Kayentis’ clients recommend Kayentis as eCOA and DCT provider in 2023.
-
Gain insight on how a single point of entry can improve patient and site experience by offering best-in-class eCOA, consent management, and patient engagement solutions.
-
Discover how Kayentis' governance structure is made to manage Big Pharma needs and builds long-term relationships.
-
Benefit from Kayentis’ data management culture for all your clinical studies and consider data management at each step of your study.
-
Learn how the Kayentis Media Player (KMP) allows relevant information to be provided regularly through very user-friendly technology.
-
Get the flexibility to customize questionnaire design with illustrations that are a better fit for population preferences, especially in young patient populations completing outcome assessments.
-
Learn more about this complementary data collection mode that further improves patients’ comfort while decreasing site burdens and enhancing clinical outcomes.
-
Learn how Kayentis can reduce project CO2 emissions without impacting cost, quality or timelines.
-
As the digitalization of clinical trials accelerates, explore how using the single platform and implementing robust technology integration from Kayentis will help to improve patients’ experience.
-
Kayentis offers extensive expertise in dermatology with a solid experience with several typical PROs and Patient Diaries.
-
Being human means that the way data is completed can create inconsistencies, issues, and more questions than you had perhaps anticipated. That is why it is essential to consider data management from the very start of each study.
-
Read about how Kayentis developed innovative eCOA solutions for capturing the patient’s voice in clinical trials.
-
Kayentis is a Global Provider Of Electronic Clinical Outcome Assessments for capturing the patient’s voice in clinical trials.